This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Radiation Therapy  • Neoplasms  • Wound Healing  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

Alfred F. Ammoury, MD; Fouad El Sayed, MD; Jacques Bazex, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Adjuvant therapies for cutaneous melanoma have been well studied, and to our knowledge only high-dose interferon alfa-2b shows reproducible benefit.¹ Efforts to improve the toxic effects profile of high-dose regimens have included the use of lower doses. We report a case of delayed wound healing secondary to treatment with low-dose interferon alfa-2b for cutaneous melanoma.

Report of a Case

A 23-year-old woman, skin phototype II, presented with a 3-month history of a slowly growing, nodular, achromic lesion on the left calf. Apart from frequent sunburn, she had been well. Histologic examination revealed an ulcerated superficial spreading melanoma 4.8-mm thick, Clark level 4, without signs of regression. Her treatment consisted of a 3-cm-wide excision followed by LLL-plasty. Sentinel lymph node dissection of the left inguinal region revealed 3 nonmetastatic lymph nodes. The disease was classified as a stage IIC (2002 American Joint Committee on . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION